Press Release

Autolus – $173 Million IPO

July 9, 2018

Reston – July 9, 2018 – Cooley advised Autolus Therapeutics on its $172.5 million initial public offering of 10,147,059 American Depositary Shares, which includes the full exercise of the underwriters’ option to purchase additional shares. Cooley partners Christian Plaza, Darren DeStefano and Brian Leaf led the team advising Autolus. 

Goldman Sachs & Co. and Jefferies acted as joint book-running managers for the offering. Wells Fargo Securities and William Blair & Company acted as lead managers.

London-based Autolus, which now trades on the Nasdaq Global Select Market under the symbol “AUTL,” is a clinical-stage biopharmaceutical company developing next-generation, programmed T cell therapies for the treatment of cancer.

About Cooley LLP

Clients partner with Cooley on transformative deals, complex IP and regulatory matters, and high-stakes litigation, where innovation meets the law. 

Cooley has 900+ lawyers across 13 offices in the United States, China and Europe.